News
MKGAF
130.15
NaN%
--
Sandoz creates biosimilar unit to benefit from major patent cliff
Seeking Alpha · 4d ago
Weekly Report: what happened at MKGAF last week (0302-0306)?
Weekly Report · 6d ago
Merck KGaA falls on lackluster guidance for 2026
Seeking Alpha · 03/05 17:39
Merck KGaA Non-GAAP EPS of €8.34, revenue of €21.1B; introduces FY26 outlook
Seeking Alpha · 03/05 08:41
Here are the major earnings before the open Thursday
Seeking Alpha · 03/04 23:00
Weekly Report: what happened at MKGAF last week (0223-0227)?
Weekly Report · 03/02 09:32
Weekly Report: what happened at MKGAF last week (0216-0220)?
Weekly Report · 02/23 09:31
ClearBridge International Value Strategy adds RHHBY and MKGAF; exits GRRMF, AKESF, and HKMPF
Seeking Alpha · 02/19 17:35
Pfizer says cancer therapy Braftovi improved survival in late-stage trial
Seeking Alpha · 02/17 14:11
Weekly Report: what happened at MKGAF last week (0209-0213)?
Weekly Report · 02/16 09:31
Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
Benzinga · 02/12 11:28
Weekly Report: what happened at MKGAF last week (0202-0206)?
Weekly Report · 02/09 09:32
Novo adds new U.S. chief amid sales decline
Seeking Alpha · 02/04 16:11
Weekly Report: what happened at MKGAF last week (0126-0130)?
Weekly Report · 02/02 09:32
TrumpRx expected to launch on Friday: report
Seeking Alpha · 01/28 18:13
Weekly Report: what happened at MKGAF last week (0119-0123)?
Weekly Report · 01/26 09:32
Weekly Report: what happened at MKGAF last week (0112-0116)?
Weekly Report · 01/19 09:35
Weekly Report: what happened at MKGAF last week (0105-0109)?
Weekly Report · 01/12 09:34
Weekly Report: what happened at MKGAF last week (1229-0102)?
Weekly Report · 01/05 09:32
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
More
Webull provides a variety of real-time MKGAF stock news. You can receive the latest news about Merck through multiple platforms. This information may help you make smarter investment decisions.
About MKGAF
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.